On June 6, 2022, Mithril Capital Management LLC announced that it has filed a definitive proxy statement with SEC and urged the shareholders of Adagio Therapeutics Inc to vote for its board nominees Tamsin Berry, Marc Elia and Clive A. Meanwell, and declassification proposal, at the annual meeting of shareholders scheduled to be held on June 22, 2022.